S15:01 Safety and efficacy of CD19 NEX-T® (BMS-986353)—a CD19-directed chimeric antigen receptor (CAR) T cell therapy—for severe refractory systemic lupus erythematosus (SLE): breakfree-1 trial update
Oral Presentations | March 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: A24-A25
10.1136/lupus-2026-el.21